Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency

Nature Genetics

Volumn 35, Issue 4, 2003, Pages 367-371

  Irwin, William A ^a   Bergamin, Natascha ^a   Sabatelli, Patrizia ^b   Reggiani, Carlo ^a   Megighian, Aram ^a   Merlini, Luciano ^b   Braghetta, Paola ^a   Columbaro, Marta ^b   Volpin, Dino ^a   Bressan, Giorgio M ^a   Bernardi, Paolo ^a   Bonaldo, Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; CALCIUM ION; COLLAGEN TYPE 6; CYCLOSPORIN A; OLIGOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL ULTRASTRUCTURE; COLLAGEN TYPE 6 DEFICIENCY; CONTROLLED STUDY; DEPOLARIZATION; DEREGULATION; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; IN VIVO STUDY; MALE; MITOCHONDRION; MOUSE; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE STRENGTH; MYOPATHY; NONHUMAN; PERMEABILITY; POROSITY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SARCOPLASMIC RETICULUM; STRUCTURE ANALYSIS;

ANIMALS; APOPTOSIS; CALCIUM; COLLAGEN TYPE VI; CYCLOSPORINE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; FIBROBLASTS; HOMOZYGOTE; IMMUNOSUPPRESSIVE AGENTS; IN SITU NICK-END LABELING; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL DISEASES; MUSCLE, SKELETAL; MUSCULAR DISEASES; OLIGOMYCINS; SARCOPLASMIC RETICULUM;

ANIMALIA;

EID: 10744233522     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1270     Document Type: Article

References (26)

1. Keene, D.R., Engvall, E. & Glanville, R.W. Ultrastructure of type VI collagen in human skin and cartilage suggests an anchoring function for this filamentous network. J. Cell Biol. 107, 1995-2006 (1988).
2. Bonaldo, P., Russo, V., Bucciotti, F., Doliana, R. & Colombatti, A. Structural and functional features of the α3 chain indicate a bridging role for chicken collagen VI in connective tissues. Biochemistry 29, 1245-1254 (1990).
3. Timpl, R. & Chu, M.L. Microfibrillar collagen type VI. in Extracellular Matrix Assembly and Structure (eds. Yurchenco, P.D., Birk, D.E. & Mecham, R.P.) 208-242 (Academic, Orlando, 1994).
4. Jöbsis, G.J. et al. Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. Nat. Genet. 14, 113-115 (1996).
5. Camacho Vanegas, O. et al. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc. Natl. Acad. Sci. USA 98, 7516-7521 (2001).
6. Bonaldo, P. et al. Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. Hum. Mol. Genet. 7, 2135-2140 (1998).
7. Plant, D.R. & Lynch, G.S. Excitation-contraction coupling and sarcoplasmic reticulum function in mechanically skinned fibres from fast skeletal muscles of aged mice. J. Physiol. 543, 169-176 (2002).
8. Irwin, W. et al. Bupivacaine myotoxicity is mediated by mitochondria. J. Biol. Chem. 277, 12221-12227 (2002).
9. Nicholls, D.G. & Ward, M.W. Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci. 23, 166-174 (2000).
10. D'hahan, N. et al. Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP. Proc. Natl. Acad. Sci. USA 96, 12162-12167 (1999).
11. Gugliucci, A. et al. Mitochondria are direct targets of the lipoxygenase inhibitor MK886. A strategy for cell killing by combined treatment with MK886 and cyclooxygenase inhibitors. J. Biol. Chem. 277, 31789-31795 (2002).
12. Bernardi, P., Petronilli, V., Di Lisa, F. & Forte, M. A mitochondrial perspective on cell death. Trends Biochem. Sci. 26, 112-117 (2001).
13. Griffiths, E.J. & Halestrap, A.P. Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase. Biochem. J. 274, 611-614 (1991).
14. Bowser, D.N., Minamikawa, T., Nagley, P. & Williams, D.A. Role of mitochondria in calcium regulation of spontaneously contracting cardiac muscle cells. Biophys. J. 75, 2004-2014 (1998).
15. 2+ uptake. FASEB J. 16, 1105-1107 (2002).
16. 2+ indicators with greatly improved fluorescent properties. J. Biol. Chem. 260, 3440-3450 (1985).
17. 2+ release channels. J. Biol. Chem. 276, 13810-13816 (2001).
18. Robert, V. et al. Alteration in calcium handling at the subcellular level in mdx myotubes. J. Biol. Chem. 276, 4647-4651 (2001).
19. Tews, D.S. Apoptosis and muscle fibre loss in neuromuscular disorders. Neuromuscul. Disord. 12, 613-622 (2002).
20. Klöhn, P.C. et al. Early resistance to cell death and to onset of the mitochondrial permeability transition during hepatocarcinogenesis with 2-acetylaminofluorene. Proc. Natl. Acad. Sci. USA 100. 10014-10019 (2003).
21. Blake, D.J. Weir, A., Newey, S.E. & Davies. K.E. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev 82, 291-329 (2002).
22. Howell, S.J. & Doane, K.J. Type VI collagen increases cell survival and prevents anti-β1 integrin-mediated apoptosis. Exp. Cell Res. 241, 230-241 (1998).
23. Rühl, M. et al. Soluble collagen VI drives serum-starved fibroblasts through S phase and prevents apoptosis via down-regulation of Bax. J. Biol. Chem. 274, 34361-34368 (1999).
24. Werner, E. & Werb. Z. Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases. J. Cell Biol. 158, 357-368 (2002).
25. Rossi, R., Bottinelli, R., Sorrentino, V. & Reggiani, C. Response to caffeine and ryanodine receptor isoforms in mouse skeletal muscles. Am. J. Physiol. 281, C595-C602 (2001).
26. Germinario, E. et al. Early changes of type 2B fibers after denervation of rat EDL skeletal muscle. J. Appl. Physiol. 92, 2045-2052 (2002).